Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641489-24-000066
Filing Date
2024-09-23
Accepted
2024-09-23 16:28:59
Documents
6
Effectiveness Date
2024-09-23

Document Format Files

Seq Description Document Type Size
1 S-8 vtv-formsx8equityincentive.htm S-8 73376
2 EX-FILING FEES exhibit107-vtvxfilingfees.htm EX-FILING FEES 14216
3 EX-4.5 exhibit452024equityincenti.htm EX-4.5 220361
4 EX-5.1 exhibit51opinionofcovingto.htm EX-5.1 9301
5 EX-23.1 exhibit231eyconsent.htm EX-23.1 2410
6 GRAHPIC image_3.jpg GRAPHIC 5578
  Complete submission text file 0001641489-24-000066.txt   328632
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282290 | Film No.: 241316544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)